Laboratory medicine plays a crucial role in the current COVID-19 pandemic and in its management. Nucleic acid-based detection of the virus is the key molecular genetic parameter in the detection of infections and several million tests have now been performed worldwide.
The Committee for molecular diagnostics (C-MD) of the IFCC would now like to ask all colleagues in clinical laboratories in each country what the current status quo in diagnostics is. We would like to understand how laboratories around the world are managing their processes during the COVID 19 outbreak.
The survey will take 10 minutes of your time and you can choose between a Spanish or English version.
We would be very pleased if you could participate in the survey until October 7th.
Please complete the survey and distribute it to all clinical colleagues in your country who perform molecular genetic detection of SARS-CoV2.
Kindly be informed that the survey deadline has been extended to next October 17th.
Thank you very much for your cooperation
International Federation of Clinical Chemistryand Laboratory Medicine (IFCC)